NeoGenomics, Inc. EPS (Earnings per Share) 2010–2025
NeoGenomics, Inc. reported $0.00 of earnings per share for fiscal 2025.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.00 | — |
| FY 2024 | $0.00 | — |
| FY 2023 | $0.00 | — |
| FY 2022 | $0.00 | — |
| FY 2021 | $0.00 | — |
| FY 2020 | $0.00 | — |
| FY 2019 | $0.00 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | +100.0% |
| FY 2015 | $-0.04 | -300.0% |
| FY 2014 | $0.02 | -50.0% |
| FY 2013 | $0.04 | — |
| FY 2012 | $0.00 | +100.0% |
| FY 2011 | $-0.03 | — |
| FY 2010 | $0.00 | — |
Source: NeoGenomics, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open NEO 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
NeoGenomics, Inc. reported $0.00 of earnings per share for fiscal 2025. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for NeoGenomics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeoGenomics, Inc. — frequently asked questions
What is NeoGenomics, Inc.'s earnings per share?
NeoGenomics, Inc. (NEO) reported earnings per share of $0.00 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from NeoGenomics, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.